Jaguar Health, Inc. (NASDAQ:JAGX)

PRESS RELEASE

published on 12/06/2023 at 14:30, 2 years 6 months ago

Study Data on Quality of Life for Breast Cancer Patients and Survivors, Supported by Napo Pharmaceuticals (a Jaguar Health Family Company), Published on San Antonio Breast Cancer Symposium (SABCS) Website
Napo Pharmaceuticals and Advocates for Collaborative Education (ACE) have released the abstract for a quality of life survey for individuals with a cancer diagnosis, shedding light on the challenges faced. The survey findings will be presented at the December 2023 SABCS, focusing on the impacts of cancer diagnosis and treatment on quality of life, including physical and emotional well-being, treatment side effects, and the consequences of managing those side effects

Napo Pharmaceuticals Advocates For Collaborative Education Cancer Survey Quality Of Life SABCS 2023
PRESS RELEASE

published on 12/04/2023 at 14:30, 2 years 6 months ago

FDA Approves Renewal of Canalevia-CA1, Jaguar Health’s Drug for Chemotherapy-Induced Diarrhea in Dogs
Jaguar Health, Inc. (NASDAQ:JAGX) has announced the renewal of conditional approval for Canalevia-CA1 (crofelemer delayed-release tablets) by the U.S. FDA for the treatment of chemotherapy-induced diarrhea (CID) in dogs. The renewal extends the validity until December 21, 2024, as the company plans a clinical field study to support full approval

Crofelemer FDA Approval Jaguar Health Canalevia-CA1 Chemotherapy-induced Diarrhea
PRESS RELEASE

published on 11/30/2023 at 14:30, 2 years 7 months ago

Jaguar Health to Present December 5 at the MedInvest Oncology Investor Conference
Jaguar Health, Inc. to present on Dec 5, 2023, at the MedInvest Oncology Investor Conference, discussing pivotal phase 3 OnTarget trial of crofelemer for prophylaxis of diarrhea in adult cancer patients receiving targeted therapy

Crofelemer Jaguar Health Oncology Investor Conference Phase 3 Clinical Trial Cancer Therapy
PRESS RELEASE

published on 11/21/2023 at 14:30, 2 years 7 months ago

Top Line Data for Jaguar Health’s Pivotal Phase 3 OnTarget Trial for Prophylaxis of Diarrhea in Adult Cancer Patients Receiving Targeted Therapy Forthcoming
PRESS RELEASE

published on 11/14/2023 at 14:00, 2 years 7 months ago

Jaguar Health Reports Third Quarter 2023 Financial Results
PRESS RELEASE

published on 11/10/2023 at 22:15, 2 years 7 months ago

Jaguar Health Announces New Employee Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
PRESS RELEASE

published on 11/09/2023 at 14:30, 2 years 7 months ago

Breast Cancer Related Results of Groundbreaking Napo Pharmaceuticals (a Jaguar Health Family Company) Supported Study on Quality of Life for Cancer Patients and Survivors Accepted for Presentation at the December 2023 San Antonio Breast Cancer Symposium
PRESS RELEASE

published on 11/08/2023 at 16:25, 2 years 7 months ago

Jaguar Health Receives Additional 180-day Grace Period to Regain Compliance with Nasdaq's Bid Price Rule
PRESS RELEASE

published on 11/08/2023 at 14:30, 2 years 7 months ago

Jaguar Health to Hold Investor Webcast Tuesday, November 14th at 8:30 AM Eastern Regarding Q3 2023 Financials & Corporate Updates
PRESS RELEASE

published on 11/07/2023 at 14:30, 2 years 7 months ago

REMINDER: Jaguar Health to Host Virtual Educational Webinar on Rare Intestinal Failure Diseases with Leading Gastroenterologists and Nutrition Experts November 8th from 1:00 PM to 2:30 PM EST

Published on 07/03/2026 at 00:45, 8 hours 35 minutes ago

FireFox Gold Finalizes Finders Fees on Recent Offering
Published on 07/03/2026 at 00:05, 9 hours 15 minutes ago

Update to Tintina Mines Previous Announcement on June 2, 2026 of a C$91 Million Private Placement and Strategic Partnership with the Gignac Family and Sumitomo Corporation for the Development of the Domeyko Sulfuros Copper-Gold Project in Chile
Published on 07/03/2026 at 00:00, 9 hours 20 minutes ago

Redwood AI Added to CSE25 Index as One of the Largest Companies Listed on the Canadian Securities Exchange
Published on 07/02/2026 at 23:05, 10 hours 15 minutes ago

AI/ML Innovations Announces Completion of Share Issuance
Published on 07/02/2026 at 19:45, 13 hours 35 minutes ago

Infield Minerals Issues Shares for Kings Canyon Gold Property Option Payment

View all ACCESSWIRE

Published on 07/03/2026 at 09:00, 19 minutes ago

Original-Research: HausVorteil AG (von NuWays AG): BUY
Published on 07/03/2026 at 09:00, 19 minutes ago

Original-Research: LION E-Mobility AG (von NuWays AG): BUY
Published on 07/03/2026 at 09:00, 20 minutes ago

Official List Notice
Published on 07/03/2026 at 09:00, 20 minutes ago

Removal - TREATT PLC
Published on 07/03/2026 at 08:40, 40 minutes ago

Hot Rocks Investments plc: New Investments

View all EQS

Published on 07/02/2026 at 18:00, 15 hours 20 minutes ago

Outstanding shares and voting rights statement at 30 June 2026
Published on 07/02/2026 at 17:45, 15 hours 35 minutes ago

ENGIE to build more than 400 km of new power transmission lines in Peru
Published on 07/02/2026 at 17:45, 15 hours 35 minutes ago

Information concerning the total number of voting rights and shares 2026 06 30
Published on 07/02/2026 at 17:45, 15 hours 35 minutes ago

EURAZEO COMPLETES THE SALE OF ITS STAKE IN SPANISH HOTEL GROUP FST HOTELS
Published on 07/02/2026 at 17:43, 15 hours 37 minutes ago

Aéroports de Paris SA - Shares and voting rights as of 30 June 2026

View all LES ECHOS COMFI WIRE

News